Evidence map›Paper›PMID 32912335›Full record

ArticleCell communication and signaling : CCS2020

SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2.

Emma Barroso, Rosalía Rodríguez-Rodríguez, Mohammad Zarei, Javier Pizarro-Degado, Anna Planavila, Xavier Palomer, Francesc Villarroya, Manuel Vázquez-Carrera

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Heliyon · 2024
    Article
  13. Review
  14. Role of lipins in cardiovascular diseases.Lipids in health and disease · 2023
    Review
  15. Review
  16. Review
  17. The role of hypoxia-inducible factor 1α in hepatic lipid metabolism.Journal of molecular medicine (Berlin, Germany) · 2023
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Emma BarrosoDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain.
Rosalía Rodríguez-RodríguezDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain.
Mohammad ZareiDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain.
Javier Pizarro-DegadoDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain.
Anna PlanavilaResearch Institute-Hospital Sant Joan de Déu, L'Hospitalet de Llobregat, Spain.
Xavier PalomerDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain.
Francesc VillarroyaResearch Institute-Hospital Sant Joan de Déu, L'Hospitalet de Llobregat, Spain.
Manuel Vázquez-CarreraDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain. mvazquezcarrera@ub.edu.ORCID 0000-0001-7138-8207
Hospital Sant Joan de Déu Barcelona · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDeficiency of mitochondrial sirtuin 3 (SIRT3), a NAD

methodsStudies were conducted in wild-type (WT) and Sirt3

resultsSirt3

conclusionThese findings demonstrate new mechanisms by which Sirt3 deficiency contributes to hepatic steatosis. Video abstract.

Indexed as

AnimalsCD36 AntigensCell LineFatty LiverGene DeletionHumansHypoxia-Inducible Factor 1, alpha SubunitLipogenesisMaleMice, Inbred C57BLNF-E2-Related Factor 2Phosphatidate PhosphataseSignal TransductionSirtuin 3CD36 AntigensHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitLpin1 protein, mouseNfe2l2 protein, mouseNF-E2-Related Factor 2Phosphatidate PhosphataseSirt3 protein, mouseSirtuin 3CD36Hepatic steatosisHFDHIF-1αLIPIN1NQO1Nrf2PPARαSirt3VLDLR

Identifiers

PMID32912335
PMCPMC7488148
OpenAlexW3083782167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.